[Drug interactions: new mechanisms and clinical relevance]

Internist (Berl). 2000 Apr;41(4):338-43. doi: 10.1007/s001080050515.

[Article in German]

Authors

A Paneitz¹, K Meissner, H K Kroemer

Affiliation

¹ Institut für Pharmakologie, Ernst-Moritz-Arndt-Universität, Greifswald.

PMID: 10798181
DOI: 10.1007/s001080050515

No abstract available

Publication types

Review

MeSH terms

ATP Binding Cassette Transporter, Subfamily B, Member 1 / metabolism
ATP-Binding Cassette Transporters / metabolism
Calcium Channel Blockers / adverse effects
Carrier Proteins / genetics
Carrier Proteins / metabolism*
Cytochrome P-450 Enzyme System / genetics
Cytochrome P-450 Enzyme System / metabolism*
Drug Interactions / physiology*
Drug Resistance, Multiple / genetics
Drug Resistance, Multiple / physiology
Drug-Related Side Effects and Adverse Reactions
Humans
Mibefradil / adverse effects
Pharmacokinetics*
Polymorphism, Genetic

Substances

ATP Binding Cassette Transporter, Subfamily B, Member 1
ATP-Binding Cassette Transporters
Calcium Channel Blockers
Carrier Proteins
Mibefradil
Cytochrome P-450 Enzyme System